Related Experiment Video
Updated: Aug 15, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line
M R Iantosca1, C E McPherson, S Y Ho
1Division of Neurosurgery, University of Connecticut Health Center, Farmington 06030-3405, USA.
Abstract:
Similarities between primitive neuroectodermal tumors and central nervous system (CNS) progenitor cells have evoked interest in the response of these tumors to endogenous growth factors. The bone morphogenetic proteins (BMPs) have recently been found to regulate survival and differentiation of CNS progenitor cell populations. In this study, we investigated the effects of BMP-2, BMP-4, and BMP-6 on the undifferentiated cerebellar primitive neuroectodermal tumor or medulloblastoma cell line DAOY. Analysis by reverse transcriptase-polymerase chain reaction showed that mRNAs for type IA and type II BMP receptors were present in control cultures. In cultures treated with BMP-2, mRNAs for BMP receptor type IB and the activin R-I receptor became evident. Cultures were analyzed for total cell counts, proliferating cell nuclear antigen (PCNA), and apoptotic DNA fragmentation. There was a significant increase in total cell number in the BMP-2 and BMP-4 treatment groups, without any change in PCNA reactivity, and a dramatic decrease in the proportion of apoptotic nuclei at concentrations of BMP-2 and BMP-4 above 5 ng/ml (P<0.001). These effects were not observed with BMP-6, TGF-beta1 or GDNF. These results suggest that the increase in total cell number is due to the attenuation of apoptosis by BMP-2 and BMP-4. The anti-apoptotic effect of BMP-2 and BMP-4 on this neuroectodermal cell line has potential clinical implications for neuroectodermal tumors.
Insights
Bone morphogenetic proteins (BMPs) like BMP-2 and BMP-4 significantly reduce apoptosis in primitive neuroectodermal tumor cells. This anti-apoptotic effect suggests potential therapeutic strategies for these central nervous system tumors.
Area of Science:
- Neuro-oncology
- Developmental Biology
- Molecular Biology
Background:
- Primitive neuroectodermal tumors (PNTs) share similarities with central nervous system (CNS) progenitor cells.
- Bone morphogenetic proteins (BMPs) are known regulators of CNS progenitor cell survival and differentiation.
Purpose of the Study:
- To investigate the effects of BMP-2, BMP-4, and BMP-6 on the DAOY medulloblastoma cell line.
- To determine if BMPs influence the survival and proliferation of these tumor cells.
Main Methods:
- Reverse transcriptase-polymerase chain reaction (RT-PCR) to detect BMP receptor expression.
- Cell counting to assess total cell number.
- Proliferating cell nuclear antigen (PCNA) staining for proliferation.
- Assay for apoptotic DNA fragmentation.
Main Results:
- DAOY cells express BMP receptor type IA and II; BMP-2 treatment induced expression of BMP receptor type IB and activin R-I.
- BMP-2 and BMP-4 significantly increased total cell number.
- BMP-2 and BMP-4 markedly decreased apoptotic DNA fragmentation at concentrations above 5 ng/ml.
- No significant effects were observed with BMP-6, TGF-beta1, or GDNF.
Conclusions:
- BMP-2 and BMP-4 attenuate apoptosis in the DAOY medulloblastoma cell line.
- The increase in cell number is primarily due to reduced apoptosis, not increased proliferation.
- These findings suggest a potential therapeutic role for BMP-2 and BMP-4 in treating primitive neuroectodermal tumors.
More Related Videos
10:02Ex Vivo Culture of Chick Cerebellar Slices and Spatially Targeted Electroporation of Granule Cell Precursors
Published on: December 14, 2015
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Abnormal Proliferation
Apoptosis
Caspases
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy